Clinical
RSSArticles
-
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with Paxlovid occurs in a tiny percentage of patients and generally is mild and self-limited.
-
Inflammatory Foods Could Accelerate Brain Aging
In the Framingham Offspring cohort of subjects, those with a higher index of inflammatory foods recorded smaller brain volume, less grey matter.
-
The Value of Stress Testing in Patients with Known Coronary Artery Disease
A comparison of adenosine stress single-photon emission CT, PET, and MRI in stable patients with known coronary artery disease (CAD) showed PET to be more sensitive for detecting invasive fractional flow reserve-identified ischemic lesions. However, the sensitivity was disappointing. Patients with known CAD and new symptoms should be referred directly to invasive coronary angiography.
-
Rivaroxaban Monotherapy for Atrial Fibrillation in Coronary Artery Disease Patients
For patients with atrial fibrillation and stable coronary artery disease, rivaroxaban monotherapy was superior to dual therapy for preventing thrombotic and bleeding events and was associated with a lower mortality rate.
-
Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)
Novavax is authorized to be administered to patients age 18 years and older for active immunization to prevent COVID-19 caused by SARS-CoV-2.
-
An Over-the-Counter Birth Control Pill Could Be a Game-Changer
The application for the first OTC birth control pill in the United States marks a new chapter in the ever-changing reproductive healthcare environment of 2022. In June, Perrigo Company announced its HRA Pharma arm submitted an application to the FDA to approve its progestin-only daily birth control pill, Opill, for OTC status.
-
Research Shows High Levels of Interest for OTC Medication Abortion
A recent study that is part of a long-term research project about the possibility of OTC medication abortion found a high interest, among abortion patients, in accessing OTC abortion pills.
-
It Is a New Day for Reproductive Providers
For many in the fields of family planning and reproductive health, it is a new day — but it is not going to be a better day.
-
Repercussions of State Abortion Bans
The Supreme Court’s decision to overturn Roe v. Wade changes nearly everything for physicians who provide abortion care, especially for those in states that have banned the procedure. Reproductive health providers in abortion-ban states may face criminal charges if they perform an abortion — even when the pregnant patient’s life and health are at risk.
-
How to Answer Patients’ Questions After Abortion Bans
If you are a reproductive health clinician, OB/GYN, or someone who wants to avoid pregnancy until you are ready, then it is only natural to be worried and afraid in today’s environment in which Roe v. Wade is gone — and the rights to contraceptive care also seem to be on the chopping block in some states. Contraceptive Technology Update asked various medical, legal, and digital security experts for answers to patients’ questions.